Schroder Investment Management Group Immatics N.V. Transaction History
Schroder Investment Management Group
- $101 Billion
- Q4 2024
A detailed history of Schroder Investment Management Group transactions in Immatics N.V. stock. As of the latest transaction made, Schroder Investment Management Group holds 427,994 shares of IMTX stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
427,994
Previous 280,447
52.61%
Holding current value
$2.17 Million
Previous $3.2 Million
4.88%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
100Shares Held
78.7MCall Options Held
238KPut Options Held
727K-
Wellington Management Group LLP Boston, MA10.4MShares$52.8 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY10MShares$50.7 Million1.82% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$41 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$37.4 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$32.7 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $386M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...